Daily Cosmetic Research Analysis
Three notable studies span dermatologic technology, minimally invasive thyroid therapy, and aesthetic dentistry. A handheld confocal Raman spectroscopy method non-invasively quantified skin ceramide kinetics and correlated strongly with LCMS, a meta-analysis affirmed durable, safe thermal ablation for benign thyroid nodules with improved cosmetic outcomes, and a small RCT showed a modified upper labial frenectomy reduces scarring and pain.
Summary
Three notable studies span dermatologic technology, minimally invasive thyroid therapy, and aesthetic dentistry. A handheld confocal Raman spectroscopy method non-invasively quantified skin ceramide kinetics and correlated strongly with LCMS, a meta-analysis affirmed durable, safe thermal ablation for benign thyroid nodules with improved cosmetic outcomes, and a small RCT showed a modified upper labial frenectomy reduces scarring and pain.
Research Themes
- Non-invasive skin biophotonics for cosmetic formulation assessment
- Minimally invasive thyroid nodule therapy with cosmetic benefits
- Optimization of aesthetic dentistry surgical techniques
Selected Articles
1. Non-Invasive Depth Profiling of Base Cosmetic Formulations in the Skin Using Handheld Confocal Raman Spectroscopy.
A handheld confocal Raman spectroscopy system quantified in vivo ceramide kinetics from moisturizers in 40 subjects and showed prolonged stratum corneum retention for ceramide-based creams at 24 hours. CRS measurements strongly correlated with LCMS for ceramide NP (r=0.96), supporting non-invasive, real-time formulation assessment.
Impact: Introduces a validated, non-invasive method to directly quantify skin ceramide content, addressing limitations of TEWL and corneometry and enabling personalized skincare assessment.
Clinical Implications: Clinicians and formulators can objectively compare moisturizer performance and tailor recommendations, particularly for atopic dermatitis, by tracking ceramide delivery and retention without biopsies.
Key Findings
- Ceramide-based creams showed longer stratum corneum retention than aqueous-based creams, especially at 24 hours post-application.
- CRS quantification of ceramide NP correlated strongly with LCMS (r=0.96) in a validation subset.
- Handheld CRS provided non-invasive, in vivo depth profiling to assess absorption kinetics of cosmetic formulations.
Methodological Strengths
- In vivo, non-invasive biophotonic measurement with depth profiling
- Orthogonal validation against LCMS for ceramide NP
Limitations
- LCMS validation subset was small (n=4) and limited to ceramide NP
- Single-site study; long-term clinical outcomes and broader analyte panels were not assessed
Future Directions: Expand validation across ceramide species and lipids, assess inter-device reproducibility, and test clinical utility for guiding therapy in atopic dermatitis and xerosis.
Ceramide-based and aqueous-based moisturizers have distinct absorption and retention characteristics in skin. Conventional methods like Transepidermal Water Loss (TEWL) and Corneometry are limited by environmental factors, and no current in vivo method measures ceramide content in skin. This research explores the use of a handheld Confocal Raman Spectroscopy (CRS) system to non-invasively analyze the absorption kinetics of these moisturizers. Measurements were taken on 40 subjects, including healthy individuals (n = 20) and those with atopic dermatitis (n = 20). Results showed that ceramide-based creams retained ceramide in the stratum corneum for longer periods, particularly 24 h post-application, compared to aqueous-based creams. Validation against Liquid Chromatography-Mass Spectrometry (LCMS) for ceramide NP in four healthy subjects showed a strong correlation (r = 0.96). These findings suggest that handheld CRS can improve the evaluation of skincare formulations, advancing the development of personalized skincare solutions.
2. The long-term effects of thermal ablation for benign thyroid nodules: a systematic review and meta-analysis.
Across studies with 3-year follow-up, thermal ablation for benign thyroid nodules achieved a pooled volume reduction rate of 71.6%, a regrowth rate of 7.4%, and a major complication rate of 2.0%, with significant improvements in symptom and cosmetic scores. Subgroup analysis suggests microwave ablation may offer greater long-term volume reduction and lower regrowth than RFA or LA, with comparable safety.
Impact: Provides long-term, modality-specific evidence supporting thermal ablation as a safe, effective alternative to surgery for benign thyroid nodules, informing modality selection in practice.
Clinical Implications: Thermal ablation can be offered to patients with symptomatic or cosmetically concerning benign nodules as a durable, low-complication option; microwave ablation may be preferred when maximal volume reduction is prioritized.
Key Findings
- Pooled 3-year volume reduction rate was 71.59% with thermal ablation.
- Regrowth and major complication rates were 7.41% and 1.96%, respectively.
- Microwave ablation showed higher VRR (89.68%) and lower regrowth (1.96%) than RFA and LA, with similar safety.
Methodological Strengths
- Systematic search across MEDLINE, Embase, and Cochrane with predefined subgroup analyses
- Long-term (3-year) pooled outcomes including symptoms, cosmetic scores, and complications
Limitations
- Underlying studies were largely non-randomized with potential heterogeneity in protocols and patient selection
- Publication bias and inconsistent reporting of regrowth definitions may affect pooled estimates
Future Directions: Head-to-head randomized trials comparing MWA, RFA, and LA with standardized regrowth definitions and patient-centered outcomes; cost-effectiveness and quality-of-life analyses.
BACKGROUND: Ultrasound-guided thermal ablation has become an option for treating benign thyroid nodules. To evaluate the long-term safety and efficacy of thermal ablation for benign thyroid nodules (BTNs), cases involving 3 years of follow-up were studied via a systematic review and meta-analysis. METHODS: Studies published up to January 2024 were searched in the MEDLINE, Embase, and Cochrane Library databases; these studies included 3 years of follow-up data on patients with BTNs who underwent thermal ablation therapy. The reduction in the mean nodule volume, volume reduction rate (VRR), rate of regrowth during follow-up, compression symptoms, postoperative cosmetic effects, and ablation complications during follow-up were analyzed over 3 years. In a subgroup analysis, laser ablation (LA), radiofrequency ablation (RFA), and microwave ablation (MWA) were compared. RESULTS: After 3 years of follow-up, the volumes of BTNs decreased significantly after thermal ablation (p < 0.00001). The VRR was 71.59%. The regrowth rate was 7.41%. The major complication rate was 1.96%. The symptom scores and cosmetic scores significantly decreased (p < 0.00001). According to our subgroup analysis, the combined VRR was 53.27% in the LA group, 79.51% in the RFA group and 89.68% in the MWA group. The regrowth rate in the MWA-treated patients was lower (1.96%) than that in the other groups. Although the rate of the major complication was slightly greater (1.96%), there were no statistically significant differences compared with those in the LA and RFA groups. CONCLUSION: Long-term follow-up analysis indicated that thermal ablation is a safe and effective method for treating benign thyroid nodules. In addition, compared with RFA and LA, MWA may be more effective at treating benign thyroid nodules. KEY POINTS: Question What is the long-term outcome of thermal ablation in the treatment of benign thyroid nodules? Findings Thermal ablation is safe and effective for benign thyroid nodules. Clinical relevance Laser ablation, radiofrequency ablation, and microwave ablation showed no difference in safety, but microwave ablation may be more effective in treating benign thyroid nodules.
3. Comparative evaluation of modified frenectomy with papilla preservation flap versus conventional technique in upper labial frenectomy: a randomized controlled trial.
In 20 randomized patients with diastema and abnormal upper labial frenum, a modified frenectomy with a papilla-preservation flap reduced papillary scarring (no scar in 9/10) versus the traditional Archer technique (scar in 7/10). Postoperative pain scores were consistently lower with the modified technique without increasing gingival inflammation.
Impact: Demonstrates a simple surgical modification that improves aesthetic and comfort outcomes in a common cosmetic dental procedure.
Clinical Implications: For upper labial frenectomy in adults with diastema, the papilla-preservation flap technique can be considered to minimize papillary scarring and reduce postoperative pain.
Key Findings
- Papillary scarring was avoided in 9 of 10 patients with the modified technique, while scarring occurred in 7 of 10 with the traditional Archer technique.
- No significant difference in postoperative gingival inflammation between groups.
- Lower postoperative pain with the modified technique on day 1 (1.5 vs 2.8) and day 3 (4.3 vs 6.9); pain decreased by day 7 in both groups.
Methodological Strengths
- Randomized controlled design directly comparing two surgical techniques
- Clinically meaningful endpoints (scarring, pain) assessed
Limitations
- Small sample size (n=20) limits precision and generalizability
- Short-term follow-up; blinding and standardized scar assessment scales not described
Future Directions: Larger, multicenter RCTs with standardized aesthetic scales and longer follow-up to assess relapse of diastema and long-term scar quality.
INTRODUCTION: Cosmetic concerns among patients have led to an increased demand for dental treatments aimed at achieving a perfect smile. One of the main cosmetic issues in adults is the gap between the upper incisors, known as diastema, and the upper lip frenulum is often a contributing factor to this condition. Therefore, it is imaportant to focus on this aspect. OBJECTIVE: To explore a new technique for cutting the upper lip frenulum in patients with a gap between the central incisors while avoiding the negative effects of the traditional technique. MATERIALS AND METHODS: This randomized controlled clinical trial included 20 patients diagnosed with abnormal upper lip frenal attachment and diastema between the central incisors. The study compared the modified frenectomy technique with a papilla preservation flap against the traditional "Archer" technique. Each technique was performed on 10 patients, and outcomes such as scar formation, gingival inflammation, and post-surgical pain were evaluated. RESULTS: The "modified frenectomy with papilla preservation flap" technique prevented scar formation in the papilla area between the upper incisors in nine cases, while scar formation occurred in seven cases using the traditional technique. There were no statistically significant differences in gingival inflammation post-surgery. Pain levels were lower with the modified technique: on the first day, the average pain score was 1.5 for the modified technique and 2.8 for the traditional technique. By the third day, the average pain was 4.3 for the modified technique and 6.9 for the traditional technique, with pain decreasing by the seventh day to an average of 0.7 for the modified technique and 1.6 for the traditional technique. CONCLUSION: The modified frenectomy with a papilla protection flap effectively reduces scarring, enhances healing, and minimizes postoperative pain, offering a more comfortable and aesthetically better result than conventional methods.